The pioneering work of Dr. William Coley has shown that infections can stimulate the immune system and improve tumor growth control. However, the immune mechanisms responsible for the protective role of infectious agents have still not been identified. Here, we investigated the role of innate immune pathways in tumor regression by performing experimental infections in genetically modified Drosophila that develop invasive neoplastic tumors. After quantifying tumor size, through image processing, and immune gene expression with transcriptomic analyses, we analyzed the link between tumor size and pathogen-induced immune responses thanks to a combination of statistical and mathematical modeling. Drosophila larvae infected with a naturally-occurring bacterium showed a smaller tumor size compared to controls and fungus-infected larvae, thanks to an increase expression of Imd and Toll pathways. Our mathematical model reinforces this idea by showing that repeated acute infection could results in an even higher decrease in tumor size. Thus, our study suggests that infectious agents can induce tumor regression through the alteration of innate immune responses. This phenomenon, currently neglected in oncology, could have major implications for the elaboration of new preventive and immunotherapeutic strategies.
Introduction
Most, if not all, multicellular organisms are exposed, during their life, to a diversity of infectious agents (through contact, ingestion and inhalation, among other possibilities) that stimulate the innate immune system (1) but also let an imprint on individual's immune profile (2) . As numerous immune mechanisms are shared by anti-infection and anti-cancer responses (3) , it is theoretically expected that the personal history of infections could influence cancer cell elimination/proliferation in the body. For instance, evidences are accumulating to suggest that infectious agents may play an indirect role in tumor progression, through immunological, ecological and evolutionary interactions with immune system (4) . Moreover, early work from William Coley as well as many other reports have unambiguously linked infection to tumor regression in cancer patients (5, 6) suggesting that non-specific immunity may be particularly relevant for cancer treatment (7) . While the impact of infectious agents on the adaptive tumoral immunity has been studied in mammals (8, 9) , the activation of innate immune pathways, a non-specific first line of defense, have however been poorly investigated in term of cancer prevention.
To disentangle the role of infection-induced innate immunity in tumor burden, we performed our experiments in an invertebrate model which does not evolve an adaptive immunity (but see (10, 11) ). In this context, Drosophila is recognized as a pertinent model for the study of cancer (12) . We considered two types of acute infections, bacterial and fungal, since they trigger different immune pathways in an experimental system of Drosophila, which develops GFP-labeled invasive neoplastic tumors in larval epithelial tissues called eye-antennal discs (13) . We combined extensive image analysis with transcriptomic study of the three main immune pathways of drosophila immunity. Then, we used statistical analysis to figure out how immune expression following each kind of infection modulates accumulation of cancer cells. Finally, we developed a mathematical model calibrated with our experimental data to show that the repetitive activation of innate immunity by acute infections may represent a significant factor for cancer prevention.
Results and Discussion
We first measured the activation of innate immune pathways in response to cancer cells without infection. In Drosophila, three main pathways are responsible for driving expression of downstream effectors of innate immunity (14, 15) . Immune Deficiency (Imd) is involved in the response to Gram-negative bacterial infection (16) while Toll pathway is stimulated in response to fungi and gram-positive bacteria (17, 18) and Janus Kinase/Signal Transducer and Activator of Transcription (Jak/STAT) is activated by injury or by the presence of aberrant cells (19, 20) and upon parasitoid wasps infection (21) . qRT-PCR analysis revealed no effect of cancerous status on diptericin (dpt, a read-out for Imd pathway) neither on unpaired 3 (upd3, a key activator of Jak/STAT pathway) expression. However, the presence of tumor cells influenced drosomycin expression (drs, a read-out for Toll pathway) with cancerous larvae expressing higher level of drs than non-cancerous ones ( Figure 1A ; zvalue = 2.04, pval = 0.04). As previously reported, our results suggested that Toll pathway is activated in presence of cancer cells (22) .
Still with non-infected Drosophila, we quantified the tumor size using the number of pixels with a standardized fluorescent intensity above a given threshold (see Supplementary materials for sensitivity on this measure). Using a generalized linear mixed model, we observed that tumor size was associated with the interaction of the three immune pathways (triple interaction: χ ² = 4.6, df=1, pval = 0.03). Therefore, we used a principal component analysis (PCA) based on the expression of the three immune genes to study their complex impact on tumor growth. We found that dpt and upd3 were positively and significantly associated to the first dimension, which accounted for 61.9% of the total variance ( Figure   1B ). drs was positively associated to the second dimension, which accounted 32.3% of the total variance ( Figure 1B ). Statistical analyses showed that tumor size was significantly associated with this first dimension ( Figure 1D ; t=2.3, df = 13, pval = 0.03). Taken together, these results suggest that the activation of Toll pathway is not proportional to the number of cancer cells but that Imd and Jak/STAT activations are linked with tumor size in non-infected larvae. Accordingly, evidences have shown that upd3-dependent Jak/STAT activation in Ras v12 /scrib 1 tumors promotes tumor growth (23) . Moreover, activation of Imd pathway has also recently been reported in tumor bearing larvae, mutant for dlg or mxc (24, 25) . As we measured gene expression in whole body, and not specifically in tumor tissues, the upregulation of upd3 may have not been sufficient to be detected in cancerous larvae in our first qRT-PCR analysis.
In order to evaluate the effect of infections on tumor burden, we carried out infectious treatments on tumor bearing larvae using the gram-negative bacterium Pectobacterium carotovorum carotovorum (Pcc) or the fungal entomopathogen Beauvaria bassiana (Bb) and compared tumor growth in those conditions with non-infected larvae (see supplement materials Table S1 for prevalence data). Analysis of tumor phenotype showed that larvae orally infected by the bacterium Pcc showed smaller sizes compared to non-infected ones ( (24, 25) , it is likely that tumor size reduction induced by bacterial infection was a consequence of a general activation of the innate immune system. However, Toll pathway alone seemed to be insufficient to induce a potent elimination of cancer cells, as suggested by the absence of tumor regression in Bb-infected larvae. This might be explained by the synergistic action of both pathways already reported for several antimicrobial peptides (16) .
Nevertheless, we cannot preclude that other mechanisms, such as metabolic or microbiota alterations consequent to digestive infection, were involved in tumor size reduction. In addition, the innate immune mechanisms, observed in response to Pcc infection, are susceptible to apply to other bacteria, including those encountered by humans, as they share common antigens called pathogen-associated molecular patterns (PAMPs) (26) .
Finally, the expression of upd3 gene was significantly decreased by Pcc and Bb infection compared to non-infected larvae but only in cancerous larvae ( Figure 2D ; z-value = -2.8, pval = 0.01). Interestingly, Jak/STAT pathway has been shown to have a dual role in tumoral immune responses. On the one hand, it promotes hemocytes proliferation, which subsequently restrict tumor growth (19) but on the other hand expression of upd3 in the tumor has been shown to increase cancer cells proliferation (23) . Thus, the downregulation Jak/STAT following infection could be directly involved in tumor size reduction or a byproduct of cancer cell elimination.
Thanks to our experimental model we have been able to study the effects of one infectious event on cancer development. However, reports from Coley's experiments as well as the use of bacillus Calmette-Guerin to treat superficial bladder cancer pointed out the importance of recurrent infections to promote efficient tumor regression (6, 27) . Since it is experimentally challenging to do repeated infection on a short-lived model like Drosophila, we investigated the consequences of these different patterns of infection through a mathematical model that allows the exploration of a large number of infectious situations and where parameters have been estimated to reproduce the level of immune gene activation and tumor size observed experimentally (Supplementary materials). When this model simulated short repeated bacterial infections, we forecasted that it may result in a smaller tumor size compared to a single persistent infection (Fig. 3A) . The effect of repeated infections can be linked to the maintenance of a higher level of Jak/STAT activation (Fig. 3B) , which may act together with Imd and Toll pathways to eliminate cancer cells.
Our study demonstrates that naturally-occurring bacterial infection can promote tumor regression in Drosophila and that infection-dependent activation of the main innate immune pathways is likely to be a key driver of this regression. Since the 20 th century, radiotherapy and chemotherapy have been intensively developed to the detriment of the early attempts of immunotherapy, such as Coley's toxin (7) . However, the striking raise of immunotherapeutic strategies in the past decades, symbolized by the attribution of the 2018 Nobel Prize of Medicine, calls for a re-evaluation of the mechanisms linking infections and spontaneous tumor regression. While studies have mainly focused on adaptive immunity for the elaboration of new drugs (28), we focused on the role of innate responses. Our study, together with other recent studies in flies (24, 25) , has revealed some molecular aspects mediating the forgotten potential of the innate immune system in the control of tumor burden. (Table M3 ).
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